John Mostafa
Foot & Ankle Surgery · Brick, NJNPI 1598058554
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Biotissue Holdings Inc. at 36.8% of the total. Reporting peaked in 2024 at $4,859 and has fallen 95.4% since, to $223 in 2025.
Across 127 payments — averaging $101.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$5K
- Stryker$4K
- Novastep Inc.$3K
- Extremity Medical$173
- Paratek Pharmaceuticals, Inc.$170
- Tenex Health Inc.$158
- plus $855 from 18 others
What the payments were for
- Consulting fees$2,45019%
- Travel & lodging$4,61336%
- Food & beverage$5,33441%
- Gifts$5234%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 11 | $4,752 |
| Stryker(2 entities) | 66 | $4,209 |
| Novastep Inc. | 2 | $2,602 |
| Extremity Medical | 1 | $173 |
| Paratek Pharmaceuticals, Inc. | 11 | $170 |
| Tenex Health Inc. | 1 | $158 |
| Paragon 28, Inc. | 3 | $142 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $133 |
| Medshape, Inc. | 2 | $106 |
| Zimmer Biomet | 2 | $60 |
| Integra Lifesciences Corporation | 3 | $51 |
| Kerecis Limited | 1 | $50 |
| Linvatec Corporation | 1 | $48 |
| AstraZeneca | 1 | $47 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $43 |
| Sebela Pharmaceuticals Inc. | 2 | $36 |
| Alfasigma USA, Inc. | 2 | $27 |
| Johnson & Johnson | 1 | $20 |
| Hydrofera LLC | 1 | $17 |
| Koya Medical, Inc. | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Treace Medical Concepts, Inc. | 1 | $15 |
| Merck | 1 | $14 |
| Sandoz | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MICA$460
- CHARLOTTE$406
- CLAW II$221
- FIXOS$200
- IO FiX$173
- ORTHOLOC 2 LAPIFUSE$168
- AUGMENT INJECTABLE$168
- VITOSS$168
- PRO-TOE$168
- PECA Bunion Correction System$152
- VARIAX$145
- HOFFMANN$145
- ALLOWRAP$142
- TOTAL ANKLE$107
- ANCHORAGE$101
How this compares
$12,920 in reported general payments places this provider in the 85th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 18 | $134 |
| Doxycycline Hyclate | 25 | $119 |
| Allopurinol | 12 | $88 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Brick
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$843K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Mark SolomonCedar Knolls$232K
- Evan AdlerOld Bridge$195K
- Shane HollawellManasquan$169K
- Jacob ReinkrautRidgewood$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.